Minimally invasive thoracic surgery in lung cancer: respecting oncologic principles is the key

Background Many thoracic surgeons have tried to make lung cancer surgery less invasive. Among the minimally invasive approaches that are currently available, it is controversial which is optimal. Minimally invasive open surgery, i.e. hybrid video-assisted thoracic surgery, has been adopted for lung cancer surgery at our institute. The objective of this study was to evaluate minimally invasive open surgery in terms of perioperative outcomes over the most recent 5 years. Methods Between 2015 and 2019, 2738 patients underwent pulmonary resection for lung cancer at National Cancer Center Hospital, Japan. Among them, 2174 patients with clinical stage I lung cancer who underwent minimally invasive open surgery were included. Several perioperative parameters were evaluated. Results The patients consisted of 1092 men (50.2%) and 1082 women (49.8%). Lobectomy was performed in 1255 patients (57.7%), segmentectomy in 603 (27.7%) and wide wedge resection in 316 (14.5%). Median blood loss was 30 ml (interquartile range: 15–57 ml) for lobectomy, 17 ml (interquartile range: 10–31 ml) for segmentectomy and 5 ml (interquartile range: 2–10 ml) for wide wedge resection. Median operative time was 120 min (interquartile range: 104–139 min) for lobectomy, 109 min (interquartile range: 98–123 min) for segmentectomy and 59 min (interquartile range: 48–76 min) for wide wedge resection. Median length of postoperative hospital stay was 4 days (interquartile range: 3–5 days). The 30-day mortality rate was 0.08% for lobectomy, 0.17% for segmentectomy and 0.00% for wide wedge resection. Conclusions Minimally invasive open surgery for clinical stage I lung cancer is a feasible approach with a low mortality and a short hospital stay. Oncological outcomes need to be investigated.

show abstract

Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures

Nakagawa

Yoshida

Yotsukura

et al. 2021

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Minimally invasive thoracic surgery in lung cancer: respecting oncologic principles is the key

Abstract: Bolaños-Cubillo A. Minimally invasive thoracic surgery in lung cancer: respecting oncologic principles is the key. Ann Transl

Cited by 1 publication

References 13 publications

Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures

Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures

Contact Info

Product

Resources

About